Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates
- PMID: 8408551
- PMCID: PMC265756
- DOI: 10.1128/jcm.31.9.2332-2338.1993
Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates
Abstract
A multicenter study was done to investigate the accuracy and reproducibility of a method for determining the MICs of antimicrobial agents against the Mycobacterium avium complex in 7H12 broth with the BACTEC system. In phase I, with eight drugs and 10 strains, intralaboratory reproducibility was 95.7 to 100%, allowing a 1-dilution difference upon repeat testing. The results of phase II testing with 41 additional strains were consistent with those obtained in phase I, with good interlaboratory reproducibility. The radiometric method was validated by sampling and plating of the same broth cultures and determining, by the number of CFU per milliliter, the lowest drug concentration that inhibited more than 99% of the initial bacterial population. Three test concentrations of each drug and the tentative interpretation of results are proposed. Radiometric MIC determination has the potential to become the method of choice for clinical microbiology laboratories and evaluation of new agents for the treatment of M. avium infections, both pulmonary and disseminated.
Similar articles
-
Evaluation of a new method for rapid drug susceptibility testing of Mycobacterium avium complex isolates by using the mycobacteria growth indicator tube.J Clin Microbiol. 1998 Jan;36(1):64-7. doi: 10.1128/JCM.36.1.64-67.1998. J Clin Microbiol. 1998. PMID: 9431921 Free PMC article.
-
French multicenter study involving eight test sites for radiometric determination of activities of 10 antimicrobial agents against Mycobacterium avium complex.Antimicrob Agents Chemother. 1995 Mar;39(3):638-44. doi: 10.1128/AAC.39.3.638. Antimicrob Agents Chemother. 1995. PMID: 7793865 Free PMC article.
-
Multisite reproducibility of results obtained by two broth dilution methods for susceptibility testing of Mycobacterium avium complex.J Clin Microbiol. 2003 Feb;41(2):627-31. doi: 10.1128/JCM.41.2.627-631.2003. J Clin Microbiol. 2003. PMID: 12574258 Free PMC article.
-
Clarithromycin against Mycobacterium avium complex infections.Tuber Lung Dis. 1996 Feb;77(1):19-26. doi: 10.1016/s0962-8479(96)90070-2. Tuber Lung Dis. 1996. PMID: 8733409 Review.
-
Susceptibility testing of Mycobacterium avium complex isolates.Antimicrob Agents Chemother. 1996 Aug;40(8):1759-67. doi: 10.1128/AAC.40.8.1759. Antimicrob Agents Chemother. 1996. PMID: 8843278 Free PMC article. Review. No abstract available.
Cited by
-
Multidrug-resistant nontuberculous mycobacteria isolated from cystic fibrosis patients.J Clin Microbiol. 2014 Aug;52(8):2990-7. doi: 10.1128/JCM.00549-14. Epub 2014 Jun 11. J Clin Microbiol. 2014. PMID: 24920766 Free PMC article.
-
Differential inhibition of adenylylated and deadenylylated forms of M. tuberculosis glutamine synthetase as a drug discovery platform.PLoS One. 2017 Oct 3;12(10):e0185068. doi: 10.1371/journal.pone.0185068. eCollection 2017. PLoS One. 2017. PMID: 28972974 Free PMC article.
-
Optimization of In Vitro Mycobacterium avium and Mycobacterium intracellulare Growth Assays for Therapeutic Development.Microorganisms. 2019 Feb 1;7(2):42. doi: 10.3390/microorganisms7020042. Microorganisms. 2019. PMID: 30717247 Free PMC article.
-
Phenotypic and molecular characterization of clinical isolates of Mycobacterium elephantis from human specimens.J Clin Microbiol. 2002 Apr;40(4):1230-6. doi: 10.1128/JCM.40.4.1230-1236.2002. J Clin Microbiol. 2002. PMID: 11923337 Free PMC article.
-
Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery.Antimicrob Agents Chemother. 1996 Jun;40(6):1536-41. doi: 10.1128/AAC.40.6.1536. Antimicrob Agents Chemother. 1996. PMID: 8726034 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical